OABI

OABI

USD

OmniAb Inc. Common Stock

$1.700-0.050 (-2.857%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.750

High

$1.750

Low

$1.690

Volume

0.87M

Company Fundamentals

Market Cap

214.1M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.12M

Exchange

NGM

Currency

USD

52-Week Range

Low $1.22Current $1.700High $4.96

Related News

BusinessWire

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program

View more
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")),

View more
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
BusinessWire

OmniAb Announces Two New Appointments to its Board of Directors

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology OmniAb, Inc. (NASDAQ:OABI) today announced the appointments of Philip J.

View more
OmniAb Announces Two New Appointments to its Board of Directors